1.530USD-2.86%Mkt Cap: 25.59M USDP/E: —Last update: 2026-06-01
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United Stat…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap25.59M USD
Enterprise Value11.26M USD
Revenue (TTM)3.55M USD
Gross Profit-7.96M USD
Net Income (TTM)-12.16M USD
Revenue/Share0.2040 USD
Last Price1.530 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS57055L2060
Valuation
P/E (Trailing)—
P/E (Forward)-9.24
PEG—
EV/EBITDA—
EV/Revenue3.18
P/S7.38
P/B1.90
EPS (TTM)-0.55
EPS (Forward)-0.17
52W Range
0.810022% of range4.070
52W High4.070 USD
52W Low0.8100 USD
Profitability
Gross Margin-224.43%
Oper. Margin-338.49%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-72.42%
ROA-63.78%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.01M USD
CapEx (TTM)—
FCF Margin-147.98%
FCF Yield-20.51%
Net Debt-14.92M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio4.79
Quick Ratio4.48
Book Value/Sh0.8260 USD
Cash/Share0.8950 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateSep 16, 2016
Splits
Last Split1:10
Split DateJan 27, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)7.867 USD
Target Range5.600 USD – 10.00 USD
# Analysts3
Ownership
Shares Out.16.67M
Float13.81M
Insiders5.49%
Institutions24.29%
Short Interest
Short Ratio3.4d
Short % Float1.82%
Short % Out.1.47%
Shares Short244.97K
Short (prev mo.)190.66K
Technical
SMA 501.452 (+5.4%)
SMA 2001.320 (+15.9%)
Beta1.43
S&P 52W Chg27.94%
Avg Vol (30d)65.97K
Avg Vol (10d)58.91K
Technical Indicators
RSI (14)62.1
MACD0.0026
MACD Signal-0.0112
MACD Hist.+0.0138
BB Upper1.555 USD
BB Middle1.454 USD
BB Lower1.353 USD
BB Width13.90%
ATR (14)0.0786 USD
Vol Ratio (20d)1.37x